Situgen Med
Cord Blood Collection Device
StartupSitugen Med is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2016. Cord Blood Collection Device. Situgen Med was founded by Miki Shacham. Key investors include RAD BioMed. The company has 1-10 employees.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageSeed
- ProductReleased
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- DistrictCenter District
- Last RoundUndisclosed
- RAD BioMed
Miki ShachamCEO & Founder
2 articles covered by sources including www.biospace.com,
www.israel21c.org.
What does Situgen Med do?
SituGen is a medical device startup that has developed a comprehensive system for extracting stem-cell-rich umbilical cord blood. The companys patented SG1040 is a disposable, all-inclusive, non-contaminating collection kit designed to increase the quality of cord blood and the number of stem cells extracted. The novel device is needle-free, preventing the bottleneck effect associated with needles. SituGen is an Israel-based company and part of the Rad-Bynet Group of multinational technology companies.
Who founded Situgen Med?
Situgen Med was founded in 2016 by Miki Shacham (CEO & Founder).
What sector is Situgen Med in?
Situgen Med operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Medical Products.
Where is Situgen Med located?
Situgen Med is based in Ha-Arad Street 7, Tel Aviv-Yafo, Israel, Center District.